The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Autor: N H, Afdhal, S, Zeuzem, R T, Schooley, D L, Thomas, J W, Ward, A H, Litwin, H, Razavi, L, Castera, T, Poynard, A, Muir, S H, Mehta, L, Dee, C, Graham, D R, Church, A H, Talal, M S, Sulkowski, I M, Jacobson, Stefan, Zeuzem

Publikováno v: Journal of Viral Hepatitis

SUMMARY. Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C virus (HCV) will become a reality in the near future. In replacing interferon-based therapies, all-oral regimens are expected to be more tolerable, more effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32dbf8c55ba220471a7f0771ca060cb
https://doi.org/10.1111/jvh.12173

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Autor: A J, Muir, K-Q, Hu, S C, Gordon, K, Koury, N, Boparai, S, Noviello, J K, Albrecht, M S, Sulkowski, J, McCone

Publikováno v: Journal of viral hepatitis. 18(4)

Previous studies of chronic hepatitis C virus (HCV) treatment have demonstrated variations in response among racial and ethnic groups including poorer efficacy rates among African American and Hispanic patients. The individualized dosing efficacy vs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::96ab7248141e7c601be9381f87f569c0
https://pubmed.ncbi.nlm.nih.gov/21108699

Hepatitis C virus and HIV co-infection: a sleeping giant wakes

Autor: M S, Sulkowski

Publikováno v: The Hopkins HIV report : a bimonthly newsletter for healthcare providers. 11(1)

Advances in HIV therapy have greatly reduced the incidence of HIV-related complications and mortality, but co-infection with hepatitis C (HCV) virus is becoming more visible. The two infections share transmission routes, with injection drug users and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8ea5438844b004ae722d4993c26abadd
https://pubmed.ncbi.nlm.nih.gov/11366161

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Autor: Sterling RK; Section of Hepatology, Virginia Commonwealth University Health System, Richmond, VA 23298-0341, USA. rksterli@hsc.vcu.edu, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2006 Jun; Vol. 43 (6), pp. 1317-25.